Patient prioritisation in current practice of Brazilian hospital clinical pharmacist: a cross-sectional survey

Authors

DOI:

https://doi.org/10.30968/jhphs.2025.161.1232

Abstract

Objectives: To survey the insertion of patient prioritisation in the current practice of clinical pharmacists at Brazilian hospitals and describe the applicability of patient prioritisation criteria for clinical pharmacy developed in a Delphi study with clinical pharmacists. Methods: This was a cross-sectional, online survey. The authors developed the survey questionnaire based on studies published in the literature. Hospital pharmacists from all over Brazil were invited to participate in the survey. The authors adopted the snowball sampling strategy to replicate the questionnaire on social networks. Results: A total of 149 pharmacists agreed to participate in the survey. In clinical practice, 94 (63.1%) participants used prioritisation criteria to select patients for clinical pharmacy care, and 55 (36.9%) employed prioritisation using an interface with a computerised hospital system. Eighty-nine (74.2%) of the 120 evaluations of criteria/sub criteria assessed regarding their applicability in clinical practice obtained agreement above 70%. Conclusions: Patient prioritisation for clinical pharmacy services is frequently used in the clinical practice of pharmacists participating in the survey. Prioritization of patients for clinical pharmacy services integrated with the hospital’s computerized system is a facilitator for incorporating prioritization into care practice. Information availability and accessible data collection are relevance for criterion be used for patient prioritisation for clinical pharmacy.

Downloads

Download data is not yet available.

References

Geeson C, Wei L, Franklin BD. High-risk medicines associated with clinically relevant medication-related problems in UK hospitals: A prospective observational study. Br J Clin Pharmacol. 2020;86(1):165-169. doi:10.1111/bcp.14119

Alshakrah MA, Steinke DT, Lewis PJ. Patient prioritization for pharmaceutical care in hospital: A systematic review of assessment tools [published correction appears in Res Social Adm Pharm. 2020 Jul;16(7):993. doi: 10.1016/j.sapharm.2020.04.010.]. Res Social Adm Pharm. 2019;15(6):767-779. doi:10.1016/j.sapharm.2018.09.009

Abuzour AS, Hoad-Reddick G, Shahid M, et al. Patient prioritisation for hospital pharmacy services: current approaches in the UK. Eur J Hosp Pharm. 2021;28(Suppl 2):e102-e108. doi:10.1136/ejhpharm-2020-002365

Falconer N, Barras M, Cottrell N. How hospital pharmacists prioritise patients at high-risk for medication harm. Res Social Adm Pharm. 2019;15(10):1266-1273. doi:10.1016/j.sapharm.2018.11.003

Santos Júnior GAD, Ramos SF, Pereira AM, et al. Perceived barriers to the implementation of clinical pharmacy services in a metropolis in Northeast Brazil. PLoS One. 2018;13(10):e0206115. Published 2018 Oct 22. doi:10.1371/journal.pone.0206115

Flynn A, Mo H, Nguyen JV, et al. Initial study of clinical pharmacy work prioritization tools. Am J Health Syst Pharm. 2018;75(15):1122-1131. doi:10.2146/ajhp170398

Martinbiancho JK, Zuckermann J, Mahmud SD, et al. Development of Risk Score to Hospitalized Patients for Clinical Pharmacy Rationalization in a High Complexity Hospital. Am J Health Syst Pharm. 2011;30:1342-1349.

Geeson C, Wei L, Franklin BD. Medicines Optimisation Assessment Tool (MOAT): a prognostic model to target hospital pharmacists’ input to improve patient outcomes. Protocol for an observational study [published correction appears in BMJ Open. 2017 Aug 1;7(7):e017509corr1. doi: 10.1136/bmjopen-2017-017509corr1.]. BMJ Open. 2017;7(6):e017509. Published 2017 Jun 14. doi:10.1136/bmjopen-2017-017509.

Schepel L, Aronpuro K, Kvarnström K, et al. Strategies for improving medication safety in hospitals: Evolution of clinical pharmacy services. Res Social Adm Pharm. 2019;15(7):873-882. doi:10.1016/j.sapharm.2019.02.004.

Geeson C, Wei L, Franklin BD. Development and performance evaluation of the Medicines Optimisation Assessment Tool (MOAT): a prognostic model to target hospital pharmacists’ input to prevent medication-related problems. BMJ Qual Saf. 2019;28(8):645-656. doi:10.1136/bmjqs-2018-008335

Botelho SF, Neiva Pantuzza LL, Marinho CP, et al. Prognostic prediction models and clinical tools based on consensus to support patient prioritization for clinical pharmacy services in hospitals: A scoping review. Res Social Adm Pharm. 2021;17(4):653-663. doi:10.1016/j.sapharm.2020.08.002.

Santos TR, Penm J, Baldoni AO, et al. Hospital pharmacy workforce in Brazil. Hum Resour Health. 2018; 16:1 doi: 10.1186/s12960-021-00680-2

Botelho SF, Pantuzza LLN, Marinho CP, Reis AMM. Consensus on the criteria for patient prioritization in hospital clinical pharmacy services: a Delphi study. Int J Clin Pharm. 2022;44(4):985-992. doi:10.1007/s11096-022-01424-5.

Lima TM, Aguiar PM, Storpirtis S. Development and validation of key performance indicators for medication management services provided for outpatients. Res Social Adm Pharm. 2019;15(9):1080-1087. doi:10.1016/j.sapharm.2018.09.010

Vila Torres E, Pérez Anchordoqui D, Porta Oltra B, et al. Modelo predictivo preliminar para la identificación de pacientes con oportunidades de mejora farmacoterapéutica [Preliminary prediction model for identifying patients with the possibility of pharmacotherapy improvement]. Farm Hosp. 2010;34(6):298-302. doi:10.1016/j.farma.2010.01.006

Urbina O, Ferrández O, Grau S, et al. Design of a score to identify hospitalized patients at risk of drug-related problems. Pharmacoepidemiol Drug Saf. 2014;23(9):923-932. doi:10.1002/pds.3634.

Falconer N, Barras M, Cottrell N. Systematic review of predictive risk models for adverse drug events in hospitalized patients. Br J Clin Pharmacol. 2018;84(5):846-864. doi:10.1111/bcp.13514

Dos Santos Barreto PG, Barbosa Rezende R, Dos Santos AL, et al. Fully independent validation and updating of a clinical pharmacy prioritizing risk score in an infectious disease hospital ward. Br J Clin Pharmacol. 2022;88(8):3695-3708. doi:10.1111/bcp.15312.

Hohmeier KC, McDonough SLK, Rein LJ, Brookhart AL, Gibson ML, Powers MF. Exploring the expanded role of the pharmacy technician in medication therapy management service implementation in the community pharmacy. J Am Pharm Assoc (2003). 2019;59(2):187-194. doi:10.1016/j.japh.2018.11.006.

Hohmeier KC, Shelton C, Havrda D, et al. The need to prioritize “prioritization” in clinical pharmacy service practice and implementation. Res Social Adm Pharm. 2020;16(12):1785-1788. doi:10.1016/j.sapharm.2020.04.012.

Wolff RF, Moons KGM, Riley RD, et al. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies. Ann Intern Med. 2019;170(1):51-58. doi:10.7326/M18-1376.

Falconer N, Barras M, Abdel-Hafez A, Radburn S, Cottrell N. Development and validation of the Adverse Inpatient Medication Event model (AIME). Br J Clin Pharmacol. 2021;87(3):1512-1524. doi:10.1111/bcp.14560.

Serafin, C, Junior DC, Vargas M .Perfil do farmacêutico no Brasil: relatório – Brasília: Conselho Federal de Farmácia, 2015, 44 p.

Melo AC, Galato D, Maniero HK, et al. Pharmacy in Brazil: Progress and Challenges on the Road to Expanding Clinical Practice. Can J Hosp Pharm. 2017;70(5):381-390. doi:10.4212/cjhp.v70i5.1700.

Downloads

Published

2025-03-31

How to Cite

1.
BOTELHO SF, NEIVA-PANTUZZA LL, REIS AM. Patient prioritisation in current practice of Brazilian hospital clinical pharmacist: a cross-sectional survey. J Hosp Pharm Health Serv [Internet]. 2025Mar.31 [cited 2025Apr.2];16(1):e1232. Available from: https://jhphs.org/sbrafh/article/view/1232

Issue

Section

ORIGINAL ARTICLES

Most read articles by the same author(s)